Treatment Options
505 articles
AVENGER 500 Clinical Trial Shows No Overall Survival Benefit
Data from the AVENGER 500 clinical trial explains why the trial’s goal was not met. A new trial with a different approach has launched.
I’m a Person, Not a Diagnosis
Burt Rosen discusses his life with PNET, making sure he is a person, and more than his diagnosis.
Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer
A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.
Adding Focused Radiation to Standard Pancreatic Cancer Treatment
Researchers are using IORT–intraoperative radiation therapy–to treat pancreatic cancer that cannot be surgically removed.
Finding More Targets for Pancreatic Cancer Treatment
Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.
Five Promising Researchers Leading the Charge in Treatment Advancements
Meet the five promising researchers supported by Let’s Win at the 2023 AACR Special Conference on Research: Pancreatic Cancer.
Treatments and the Importance of Clinical Trials
In a webinar, Drs. Allyson Ocean and Arturo Loaiza-Bonilla discuss pancreatic cancer treatments and why clinical trials are so important.
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
Prognosis: More Than Numbers in Pancreatic Cancer
What is pancreatic cancer prognosis? Dr. Joshua Lakin of Harvard explains how prognosis works, and ways to possibly defy the odds when facing a slow recovery.
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
Targeting Tumor Proteins Specific to Pancreatic Cancer Cells
A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.